Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0095
-0.0005 (-5.00%)
Jul 8, 2026, 12:47 PM EST
Evofem Biosciences Market Cap
Evofem Biosciences has a market cap or net worth of $1.25 million as of July 8, 2026. Its market cap has increased by 8.81% in one year.
Market Cap
1.25M
Enterprise Value
57.01M
Revenue
20.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 18, 2018, Evofem Biosciences's market cap has decreased from 215.21M to 1.25M, a decrease of -99.42%. That is a compound annual growth rate of -45.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 1.29M | 6.82% |
| Dec 31, 2025 | 1.20M | 7.24% |
| Dec 31, 2024 | 1.12M | -12.37% |
| Dec 29, 2023 | 1.28M | -83.76% |
| Dec 30, 2022 | 7.89M | -87.13% |
| Dec 31, 2021 | 61.26M | -68.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AXIM Biotechnologies | 1.55M |
| inTerra Resources | 1.47M |
| Neon Bloom | 1.26M |
| Lyra Therapeutics | 1.26M |
| Abpro Holdings | 1.25M |
| ZyVersa Therapeutics | 1.15M |
| Avenue Therapeutics | 1.00M |
| Biomind Labs | 861.05K |